Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.

Article  CAS  PubMed  Google Scholar 

Mathis S, Duchesne M, Magy L, Vallat J-M. Chapter 7 - Peripheral nervous system involvement in vasculitis. In: Rajabally YA, editor, Dysimmune neuropathies. Academic Press; 2020. pp. 145–176, ISBN 9780128145722. https://doi.org/10.1016/B978-0-12-814572-2.00007-8.

•• Gwathmey KG, Burns TM, Collins MP, Dyck PJB. Vasculitic neuropathies. Lancet Neurol. 2014;13:67–82. In-depth review of the clinical presentation and pathology findings of systemic and non-systemic vasculitic neuropathies.

Collins MP, Dyck PJB, Gronseth GS, et al. Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst. 2010;15:176–84.

Article  PubMed  Google Scholar 

Amato AA, Russell JA. Neuromuscular disorders. 2nd ed. United Kingdom: McGraw-Hill Education; 2015.

Google Scholar 

Koike H, Nishi R, Ohyama K, et al. ANCA-associated vasculitic neuropathies: a review. Neurol Ther. 2022;11:21–38.

Article  PubMed  PubMed Central  Google Scholar 

McCluskey L, Feinberg D, Charles C, Bird S. “Pseudo-conduction block” in vasculitic neuropathy. Muscle Nerve. 1999. https://doi.org/10.1002/(sici)1097-4598(199910)22:10%3c;1361::aid-mus4%3e3.0.co;2-1.

Article  PubMed  Google Scholar 

Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol. 2017;13:302–16.

Article  PubMed  Google Scholar 

Nathani D, Barnett MH, Spies J, Pollard J, Wang M, Kiernan MC. Vasculitic neuropathy: comparison of clinical predictors with histopathological outcome. Muscle Nerve. 2019;59:643–9.

Article  PubMed  Google Scholar 

Dammacco F, Ribatti D, Vacca A. Systemic vasculitides: current status and perspectives. 2016. https://doi.org/10.1007/978-3-319-40136-2.

Article  Google Scholar 

Vrancken AFJE, Gathier CS, Cats EA, Notermans NC, Collins MP. The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy. Eur J Neurol. 2011;18:49–58.

Article  CAS  PubMed  Google Scholar 

• Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Brain. 1987;110:843–53. One of the first case series of non-systemic vasculitic neuropathies. 

Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014;13:1121–5.

Article  PubMed  Google Scholar 

Stone JH, Group WGETR. Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum. 2003;48:2299–309.

Article  Google Scholar 

Holle JU, Gross WL. Neurological involvement in Wegener’s granulomatosis. Curr Opin Rheumatol. 2011;23:7–11.

Article  PubMed  Google Scholar 

Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421–30.

Article  CAS  PubMed  Google Scholar 

Hattori N, Mori K, Misu K, Koike H, Ichimura M, Sobue G. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatol. 2002;29:1408–14.

PubMed  Google Scholar 

Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65:270–81.

Article  PubMed  Google Scholar 

Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Guern VL, Bienvenu B, Mouthon L, Guillevin L, Group FVS. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French vasculitis study group database. Arthritis Rheum. 2010;62:616–26.

Article  Google Scholar 

Tulbă D, Popescu BO, Manole E, Băicuș C. Immune axonal neuropathies associated with systemic autoimmune rheumatic diseases. Front Pharmacol. 2021;12:610585.

Article  PubMed  PubMed Central  Google Scholar 

Chung SA, Seo P. Microscopic polyangiitis. Rheum Dis Clin North Am. 2010;36:545–58.

Article  PubMed  PubMed Central  Google Scholar 

Chung SA, Gorelik M, Langford CA, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of polyarteritis nodosa. Arthritis Rheumatol. 2021;73:1384–93.

Article  PubMed  Google Scholar 

•• Wallace ZS, Miloslavsky EM. Management of ANCA associated vasculitis. BMJ. 2020;368:m421. Recent review detailing the evidence for treatment of AAV. 

Chevet B, Cornec D, Moura MC, Gall EC-L, Fervenza FC, Warrington KJ, Specks U, Berti A. Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice. Rheumatology. 2022;62:1787–803.

Article  Google Scholar 

Walsh M, Merkel PA, Peh C-A, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382:622–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fauci AS, Wolff SM. Wegener’s granulomatosis: studies in eighteen patients and a revision of the literature. Medicine. 1974;52:535–61.

Article  Google Scholar 

Naddaf E, Dyck PJB. Vasculitic neuropathies. Curr Treat Options Neurol. 2015;17:44.

Article  Google Scholar 

Harper L, Morgan MD, Walsh M, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2012;71:955.

Article  CAS  PubMed  Google Scholar 

Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis. Ann Rheum Dis. 2017;76:1064.

Article  PubMed  Google Scholar 

Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36–44.

Article  CAS  PubMed  Google Scholar 

Guillevin L, Pagnoux C, Karras A, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371:1771–80.

Article  PubMed  Google Scholar 

Pagnoux C, Mahr A, Hamidou MA, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359:2790–803.

Article  CAS  PubMed  Google Scholar 

Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2011;41:203–11.

Article  PubMed  Google Scholar 

Mekinian A, Ravaud P, Hatron PY, et al. Efficacy of rituximab in primary Sjögren’s syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis. 2012;71:84.

Article  CAS  PubMed  Google Scholar 

Vrancken AF, Hughes RA, Said G, Wokke JH, Notermans NC. Immunosuppressive treatment for non‐systemic vasculitic neuropathy. Cochrane Database Syst Rev. 2007;CD006050.

Mathew L, Talbot K, Love S, Puvanarajah S, Donaghy M. Treatment of vasculitic peripheral neuropathy: A retrospective analysis of outcome. QJM Int J Med. 2007;100:41–51.

Collins MP, Periquet MI, Mendell JR, Sahenk Z, Nagaraja HN, Kissel JT. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003;61:623–30.

Article  CAS  PubMed  Google Scholar 

Üçeyler N, Geng A, Reiners K, Toyka KV, Sommer C. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. J Neurol. 2015;262:2092–100.

Article  PubMed  Google Scholar 

Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain. 1996;119:1441–8.

Article  PubMed  Google Scholar 

Staff NP, Engelstad J, Klein CJ, Amrami KK, Spinner RJ, Dyck PJ, Warner MA, Warner ME, Dyck PJB. Post-surgical inflammatory neuropathy. Brain. 2010;133:2866–80.

Article  PubMed  Google Scholar 

Rattananan W, Thaisetthawatkul P, Dyck PJB. Postsurgical inflammatory neuropathy: a report of five cases. J Neurol Sci. 2014;337:137–40.

Article  PubMed  Google Scholar 

van Alfen N, van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006;129:438–50.

Article  PubMed  Google Scholar 

Gstoettner C, Mayer JA, Rassam S, Hruby LA, Salminger S, Sturma A, Aman M, Harhaus L, Platzgummer H, Aszmann OC. Neuralgic amyotrophy: a paradigm shift in diagnosis and treatment. J Neurol, Neurosurg Psychiatry. 2020;91:879–88.

Article  PubMed  Google Scholar 

Suarez GA, Giannini C, Bosch EP, Barohn RJ, Wodak J, Ebeling P, Anderson R, McKeever PE, Bromberg MB, Dyck PJ. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology. 1996;46:559–61.

Article  CAS  PubMed  Google Scholar 

van Eijk JJJ, van Alfen N, Berrevoets M, van der Wilt GJ, Pillen S, van Engelen BGM. Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J Neurol, Neurosurg Psychiatry. 2009;80:1120.

Article